<--- Back to Details
First PageDocument Content
Immunology / Inventive step and non-obviousness / Adalimumab / Rheumatoid arthritis / Patentability / Person having ordinary skill in the art / Patent / Methotrexate / Double patenting / Patent law / Law / Civil law
Date: 2014-08-21 12:30:02
Immunology
Inventive step and non-obviousness
Adalimumab
Rheumatoid arthritis
Patentability
Person having ordinary skill in the art
Patent
Methotrexate
Double patenting
Patent law
Law
Civil law

United States Court of Appeals for the Federal Circuit ______________________ ABBVIE INC. AND ABBVIE BIOTECHNOLOGY LIMITED,

Add to Reading List

Source URL: www.finnegan.com

Download Document from Source Website

File Size: 213,29 KB

Share Document on Facebook

Similar Documents

Impact_of_Public_Disclosure

Impact_of_Public_Disclosure

DocID: 1qS8t - View Document

INVENTORSHIP NEED FOR CORRECT INVENTORSHIP From the standpoint of U.S. law, a patent is a personal entitlement of the legal inventor(s) which comes directly from the U.S. Constitution. A patent may issue lawfully only in

INVENTORSHIP NEED FOR CORRECT INVENTORSHIP From the standpoint of U.S. law, a patent is a personal entitlement of the legal inventor(s) which comes directly from the U.S. Constitution. A patent may issue lawfully only in

DocID: 1qFJ3 - View Document

Sweden Suède Schweden Report Q 167 in the name of the Swedish Group by Ulf DAHLGREN, Bo HALLDIN, Ivan HJERTMAN, Lars HÖGLUND, Per

Sweden Suède Schweden Report Q 167 in the name of the Swedish Group by Ulf DAHLGREN, Bo HALLDIN, Ivan HJERTMAN, Lars HÖGLUND, Per

DocID: 1qEhc - View Document

Microsoft Word - GR_Q217_Hungary_inclsum_260411.doc

Microsoft Word - GR_Q217_Hungary_inclsum_260411.doc

DocID: 1qz7j - View Document

Microsoft Word - Patents Ordinance 2000 _Amendments final_.doc

Microsoft Word - Patents Ordinance 2000 _Amendments final_.doc

DocID: 1qwtr - View Document